Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...

— Days after retaining the Nickles Group, Novo Nordisk also hired Checkmate Government Relations, the new D.C. outpost of a ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

You know Ozempic can help with weight loss, but how long can you stay on Ozempic exactly? Unfortunately, there isn’t a solid ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.

The Maine Legislature is considering a bill that would require MaineCare to cover popular weight loss drugs like Ozempic. The ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

Acclaimed vocalist Michael Trotter Jr. of the husband-and-wife duo The War and Treaty, reveals his diabetes diagnosis in ...